- Investing Ideas
- German Healthcare Healthy potentially undervalued
German Healthcare Healthy potentially undervalued
Results
5
Companies which are potentially undervalued and in an acceptable financial position.
5 companies
Fresenius Medical Care
Market Cap: €10.8b
Provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally.
FME
€40.93
7D
-0.2%
1Y
-5.5%
Siemens Healthineers
Market Cap: €44.5b
Through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers in Germany, the United States, rest of Europe, CIS, Africa, the Middle East, the Americas, the Asia Pacific, Japan, and China.
SHL
€39.98
7D
2.4%
1Y
-17.0%
Stratec
Market Cap: €259.5m
Provides automation solutions for in-vitro diagnostics and life science companies in Germany, the European Union, and internationally.
SBS
€21.35
7D
4.1%
1Y
-18.7%
Fresenius SE KGaA
Market Cap: €26.3b
A health care company, provides products and services for chronically ill patients in North America, Europe, the Asia-Pacific, Latin America, and Africa.
FRE
€46.65
7D
-0.4%
1Y
-1.1%
Carl Zeiss Meditec
Market Cap: €2.8b
Operates as a medical technology company in Germany, rest of Europe, North America, and Asia.
AFX
€32.24
7D
8.1%
1Y
-24.5%